Correlation Between Boston Scientific and Echo Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Boston Scientific and Echo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Boston Scientific and Echo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Boston Scientific Corp and Echo Therapeutics, you can compare the effects of market volatilities on Boston Scientific and Echo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Boston Scientific with a short position of Echo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Boston Scientific and Echo Therapeutics.

Diversification Opportunities for Boston Scientific and Echo Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Boston and Echo is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Boston Scientific Corp and Echo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Echo Therapeutics and Boston Scientific is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Boston Scientific Corp are associated (or correlated) with Echo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Echo Therapeutics has no effect on the direction of Boston Scientific i.e., Boston Scientific and Echo Therapeutics go up and down completely randomly.

Pair Corralation between Boston Scientific and Echo Therapeutics

If you would invest  6,083  in Boston Scientific Corp on January 25, 2024 and sell it today you would earn a total of  816.00  from holding Boston Scientific Corp or generate 13.41% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Boston Scientific Corp  vs.  Echo Therapeutics

 Performance 
       Timeline  
Boston Scientific Corp 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Boston Scientific Corp are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Boston Scientific showed solid returns over the last few months and may actually be approaching a breakup point.
Echo Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Echo Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Echo Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Boston Scientific and Echo Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Boston Scientific and Echo Therapeutics

The main advantage of trading using opposite Boston Scientific and Echo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Boston Scientific position performs unexpectedly, Echo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Echo Therapeutics will offset losses from the drop in Echo Therapeutics' long position.
The idea behind Boston Scientific Corp and Echo Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities